“Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker” (2025) Advances in World Medical Research, 1(2), pp. 48–63. doi:10.71204/1bcv8650.